Chiming Wei MD, PhD, FACC, FAHA, FCCP, FAAN

Dr. Chiming Wei MD, PhD, FACC, FAHA, FCCP, FAAN, is the Director of Cardiovascular Molecular Research Program at the Johns Hopkins University School of Medicine. Before joining Johns Hopkins University, he held positions in the Mayo Clinic, Harvard University and University of Maryland School of Medicine.

Dr. Wei discovered a new vasonatrain peptide (VNP) and received an American Patent. Dr. Wei has served as the President of the American Academy of Nanomedicine (AANM), Editor-in-Chief of NANOMEDICINE, and Editor-in-Chief of the Journal of Cardiothoracic-Renal Research (JCRR). The major research areas of Dr. Wei include new approach of nanomedicine in basic and clinical medicine, oxidative DNA damage and DNA repair pathways in ischemia-reperfusion injury and in cardiovascular and renal diseases.